Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 19, 2018
[Study on the immune functions of dendritic cells regulated by histone deacetylase inhibitor Belinostat]
W H Jia, H Mao, W R Chen, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
December 8, 2025
[Clinicopathological characteristics of cutaneous melanocytic tumor with CRTC1::TRIM11 fusion of three cases]
Y Y Xu, B T Fan, L Xie, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
December 4, 2024
[Progress in research of multimorbidity measurement and analysis methods]
W H Shao, Z L Lu, E Y Gong, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
December 26, 2022
[Mediation effect of smoking and healthy diet score on the association between educational level and the risk of lung cancer incidence]
H Wang, X X Wei, Z M Ma, et al.
Technology in Cancer Research & Treatment
|
May 14, 2015
Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice
C Wei, A Y Xun, X X Wei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2023
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
B A McGregor, G P Sonpavde, L Kwak, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
September 19, 2022
[Comparative analysis on prevalence of tobacco and e-cigarettes uses in junior middle school students in Shanghai, 2013 and 2019]
X X Jia, K Xu, B B Che, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2025
Final overall survival and safety analyses of the phase III PSMAfore trial of [<sup>177</sup>Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer
K Fizazi, K N Chi, N D Shore, et al.
Zhonghua Yi Xue Za Zhi
|
July 24, 2023
[Survey of <i>Helicobacter pylori</i> levofloxacin and clarithromycin resistance rates and drug resistance genes in Ningxia, 2020-2022]
L M Du, S J Hu, X M Chen, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
March 19, 2018
[Study on the immune functions of dendritic cells regulated by histone deacetylase inhibitor Belinostat]
W H Jia, H Mao, W R Chen, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|
December 8, 2025
[Clinicopathological characteristics of cutaneous melanocytic tumor with CRTC1::TRIM11 fusion of three cases]
Y Y Xu, B T Fan, L Xie, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
December 4, 2024
[Progress in research of multimorbidity measurement and analysis methods]
W H Shao, Z L Lu, E Y Gong, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
December 26, 2022
[Mediation effect of smoking and healthy diet score on the association between educational level and the risk of lung cancer incidence]
H Wang, X X Wei, Z M Ma, et al.
Technology in Cancer Research & Treatment
|
May 14, 2015
Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice
C Wei, A Y Xun, X X Wei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2023
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
B A McGregor, G P Sonpavde, L Kwak, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
September 19, 2022
[Comparative analysis on prevalence of tobacco and e-cigarettes uses in junior middle school students in Shanghai, 2013 and 2019]
X X Jia, K Xu, B B Che, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 18, 2025
Final overall survival and safety analyses of the phase III PSMAfore trial of [<sup>177</sup>Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer
K Fizazi, K N Chi, N D Shore, et al.
Zhonghua Yi Xue Za Zhi
|
July 24, 2023
[Survey of <i>Helicobacter pylori</i> levofloxacin and clarithromycin resistance rates and drug resistance genes in Ningxia, 2020-2022]
L M Du, S J Hu, X M Chen, et al.
Page
of 3